Clinical Trial to Evaluate the Efficacy and Safety of DA-5219 in Patients With Acute or Chronic Gastritis
NCT06151210 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 467
Last updated 2025-08-28
Summary
This study is to evaluate the efficacy and safety of DA-5219 in patients with acute or chronic gastritis
Conditions
- Gastritis Acute
- Gastritis Chronic
Interventions
- DRUG
-
DA-5219
1 tablet/day
- DRUG
-
Stillen® Tab
3 tablets/day
- DRUG
-
DA-5219 Placebo
1 tablet/day
- DRUG
-
Stillen® Tab Placebo
3 tablets/day
Sponsors & Collaborators
-
Dong-A ST Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-31
- Primary Completion
- 2025-07-10
- Completion
- 2025-07-15
Countries
- South Korea
Study Locations
More Related Trials
-
A Study to Evaluate the Efficacy and Safety of AD-203
NCT04066530 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Eupasidin-s Tab.(EUPASIDIN-S) in Gastritis Patients
NCT02356679 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Trial to Evaluate the Efficacy and Safety of PDC-339 for the Treatment of Acute Erosive Gastritis
NCT00854880 ·Status: COMPLETED ·Phase: PHASE2
-
A Parallel Group Study to Compare the Gastroprotective Effects of PA 325 Versus 81 mg Enteric Coated Aspirin
NCT00441519 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of PMK-S005 After Oral Administration in Healthy Male Volunteers
NCT01762397 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic Ulcer
NCT04784910 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial to Compare Rebamipide/Nizatidine Combination Therapy With Nizatidine Monotherapy in Patients With Gastritis
NCT05072938 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Efficacy and Safety of HIP2101 in Patients With Acute or Chronic Gastritis
NCT05024721 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Teprenone in Patients With Acute Gastritis, Acute Gastric Lesion of Chronic Gastritis With Acute Exacerbation or Gastric Ulcer
NCT01190657 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of MCT-SR in Patients With Gastritis
NCT04189705 ·Status: COMPLETED ·Phase: PHASE3
-
The Study Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151'
NCT06902818 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Male Volunteers
NCT02757144 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy/Safety Study as H. Pylori Eradication of Triple Therapy for 7 Days Treatment
NCT02084420 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers
NCT00960869 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Efficacy & Safety Study of D961H Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With Low-dose Aspirin
NCT01069939 ·Status: COMPLETED ·Phase: PHASE3
-
A Double-blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole Sodium
NCT00125736 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Long-Term Safety of PA32540 in Subjects Who Are at Risk for Developing Aspirin-Associated Gastric Ulcers
NCT00995410 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers
NCT00961350 ·Status: COMPLETED ·Phase: PHASE3
-
Post-Marketing Surveillance of Safety and Effectiveness of Mucosta®SR Tab.
NCT05048069 ·Status: UNKNOWN
-
A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients With Gastric Ulcer
NCT05656092 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 3)
NCT03736369 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of PMK-S005 in the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin Users
NCT02342470 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer
NCT06284876 ·Status: RECRUITING ·Phase: PHASE3
-
Comparative Efficacy & Safety Study of Esomeprazole Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With NSAID
NCT00542789 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of DLBS2411 in Healthy Volunteers
NCT01573403 ·Status: COMPLETED ·Phase: PHASE1/PHASE2